BPC-157 Research: A Comprehensive Review of Preclinical Evidence
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a segment of human gastric juice protein that has demonstrated […]
In-depth mechanism of action reviews for individual research peptides.
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a segment of human gastric juice protein that has demonstrated […]
Melanotan II is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone (alpha-MSH) studied for its broad agonism across the melanocortin
Retatrutide (LY3437943) is a first-in-class triple receptor agonist peptide that simultaneously activates GLP-1, GIP, and glucagon receptors, producing the most
GLP-1 receptor agonist peptides are synthetic analogues of glucagon-like peptide-1 that bind the GLP-1R with enhanced metabolic stability, driving sustained
NAD+ declines with age across most tissues studied, and that decline is mechanistically linked to falling sirtuin activity, rising CD38
For research purposes only. Not for human consumption. Not for diagnostic or therapeutic use. Research peptide purity above 98% by
Semaglutide is a synthetic GLP-1 receptor agonist peptide that mimics the incretin hormone glucagon-like peptide-1 with significantly extended half-life due
Canadian supplier of high-purity research compounds for laboratory and scientific applications.
BC Facility, British Columbia, Canada
[email protected]Study breakdowns, new compound alerts, and purity data. Every Monday. No spam.
For research purposes only. Unsubscribe anytime.